"I look forward to a fostering a productive relationship with Neopharm as we progress CVac through clinical trials. Neopharm is among the largest and most substantial corporations operating across the Israeli healthcare sector. Neopharm's expertise and strengths in marketing of ground-breaking pharmaceuticals and biological therapies, and in particular oncology treatments, will enable us to successfully penetrate to the Israeli market”
ann out commercial partnership neopharm
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.3¢ |
Change
-0.003(0.75%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 34.0¢ | 33.0¢ | $214.7K | 641.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 583951 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 114694 | 12 |
View Market Depth
| Last trade - 15.45pm 02/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |